The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.
In a population of cisgender men, transgender women, transgender men, and gender-nonbinary persons, the incidence of HIV is lower with receipt of twice-yearly subcutaneous lenacapavir.
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...
The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.
El Mundo on MSN7h
Drug that protects against HIV with two 'shots' a year, discovery of the year for 'Science'Lenacapavir, a treatment administered subcutaneously every six months, is capable of preventing infection with very high ...
Months Before C.E.O.’s Killing, the Suspect Went Silent. Where Was He? New details are emerging about Luigi Mangione’s growing impatience with “a capitalist society” and his search for ...
You Can Download iOS 18.2 Today, With ChatGPT, Genmoji, Visual Intelligence for iPhone ...
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., December 10, 2024. REUTERS/Brendan McDermid Wall Street pulled back on Thursday as investors evaluated key ...
President-elect Donald Trump nominated Greek American Michael Rigas for the role of Deputy Secretary of State for Management and Resources. "Michael will bring accountability to the State Department ...
Stay informed on Saudi Arabia’s rapid changes, developments, and ongoing efforts to reshape the Middle East and beyond.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback